HIV-NAT 248

Project no.: HIV-NAT 248/GSK 205670 (NCT03020745)

This is a double-blind, placebo-controlled study that will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending dose and multiple doses of GSK3389404 in chronic Hepatitis B subjects (GSK 205670).